Today: 11 June 2026
Redwire Stock Bounces as $500 Million Share Sale Draws Focus
11 June 2026

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Apple Stock Attempts Bounce After Siri AI Drop as Investors Weigh Upgrades

Apple Stock Attempts Bounce After Siri AI Drop as Investors Weigh Upgrades

11 June 2026
Apple shares edged up 0.52% premarket to $293.10 after a sharp WWDC drop, as investors focus on whether the new Siri AI can drive an iPhone upgrade cycle despite device and regional limits; over 1.3 billion iPhones can’t use advanced features, and Siri AI won’t launch in the EU or China yet, putting pressure on Apple’s next beta release to prove real adoption.
Cameco (CCJ) Drops 7% as Uranium Stocks See Investors Step Back

Cameco (CCJ) Drops 7% as Uranium Stocks See Investors Step Back

Cameco shares plunged 7.4% to $94.74 in late trading—far outpacing the 0.07% drop in Canada’s S&P/TSX—as uranium stocks broadly sold off despite no change in Cameco’s production guidance; investors now await July 31 results for confirmation that production recovery and Westinghouse progress can support the stock’s high valuation.
10 June 2026

Constellation Energy Earnings Preview: AI Power Bet Faces a 7% Stock Test

Constellation Energy Drops; Three Mile Island Restart News Runs Into AI Power Sector Selloff

Constellation Energy shares fell 3.3% to $243.32 despite regulatory progress for the Crane Clean Energy Center, as investors repriced AI-linked power stocks; the next key catalyst is the NRC’s public-comment deadline on July 8 ahead of a projected final environmental decision in September, with stock sentiment hinging on regulatory milestones and data center power demand.
BigBear.ai Stock Bounces as Shareholder Vote Squeeze Meets Panama AI Speculation

BigBear.ai Stock Bounces as Shareholder Vote Squeeze Meets Panama AI Speculation

BigBear.ai shares rose 2.8% to $4.10 as investors weighed the approved move to double authorized shares to 1 billion, giving the company flexibility for financing but raising dilution risks, while the Panama cargo-security rollout and $281.9 million backlog keep growth hopes alive amid ongoing losses and revenue conversion questions.

Latest

MARA Stock Edges Higher After Bitcoin Holds Steady, Q1 Miss and AI Uncertainty in Focus

MARA Stock Edges Higher After Bitcoin Holds Steady, Q1 Miss and AI Uncertainty in Focus

MARA surged 5.2% to $13.27 as bitcoin rebounded to $63,375, drawing investor focus after a sharp prior-session drop, even as Q1 net loss widened to $1.26 billion on lower revenue and bitcoin sales; the stock’s move reflects renewed risk appetite amid ongoing concerns over financial performance and the company’s pivot toward AI and data center infrastructure.
Ondas Stock Moves Up as LADOS Defense Platform and Share Resale Filing Get Interest

Ondas Stock Moves Up as LADOS Defense Platform and Share Resale Filing Get Interest

Ondas Inc. jumped 1.5% to $9.45 after announcing it will launch its LADOS defense command-and-control system at Eurosatory 2026, as investors weighed this catalyst against a recent SEC filing registering the resale of 2.7 million shares tied to the Omnisys acquisition; Q1 revenue surged to $50.1 million, but adjusted EBITDA loss was $10.9 million, with losses expected to peak in Q2.
IREN Bounces After Needham Cuts Targets, Market Watches AI Cloud Moves

IREN Bounces After Needham Cuts Targets, Market Watches AI Cloud Moves

IREN shares jumped over 5% midday after two steep declines, as investors weighed Needham’s cut to 2026–27 estimates—citing slower AI cloud revenue ramp—against IREN’s $3.65B GPU financing and major AI contracts. Despite the rebound, the stock remains well below its 52-week high, with analysts focused on the timing of AI revenue recognition amid the company’s shift away from Bitcoin mining.
Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Go toTop